[go: up one dir, main page]

AR058297A1 - Compuestos que contienen calciorecubiertos con una pelicula polimerica hidrosoluble y el uso de dichos compuestos recubiertos en composiciones farmaceuticas - Google Patents

Compuestos que contienen calciorecubiertos con una pelicula polimerica hidrosoluble y el uso de dichos compuestos recubiertos en composiciones farmaceuticas

Info

Publication number
AR058297A1
AR058297A1 ARP060105430A AR058297A1 AR 058297 A1 AR058297 A1 AR 058297A1 AR P060105430 A ARP060105430 A AR P060105430A AR 058297 A1 AR058297 A1 AR 058297A1
Authority
AR
Argentina
Prior art keywords
compounds
pharmaceutical compositions
compounds containing
calciorecondieres
polymeric film
Prior art date
Application number
Other languages
English (en)
Inventor
Jan Yngvar Piene
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of AR058297A1 publication Critical patent/AR058297A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A23L29/37—Sugar alcohols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31844—Of natural gum, rosin, natural oil or lac
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31971—Of carbohydrate

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Compuestos que contienen calcio han sido al menos parcialmente recubiertos con una película y/o granulados con una sustancia hidrosoluble y una sustancia polimérica hidrosoluble, y el uso de dichos compuestos recubiertos en composiciones farmacéuticas. Los compuesto que contienen calcio, al menos parcialmente recubiertos con película y/o granulados, han resultado adecuados para la preparacion de tabletas con una carga muy elevada de calcio elemental y tamano convenientemente pequeno. Se obtiene una carga de fármaco de aproximadamente 96% o más en tabletas de la presente que tienen suficientes propiedades mecánicas y organolépticas.
ARP060105430 2005-12-07 2006-12-07 Compuestos que contienen calciorecubiertos con una pelicula polimerica hidrosoluble y el uso de dichos compuestos recubiertos en composiciones farmaceuticas AR058297A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200501736 2005-12-07
DKPA200601203 2006-09-15
US85013006P 2006-10-06 2006-10-06

Publications (1)

Publication Number Publication Date
AR058297A1 true AR058297A1 (es) 2008-01-30

Family

ID=59285472

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105430 AR058297A1 (es) 2005-12-07 2006-12-07 Compuestos que contienen calciorecubiertos con una pelicula polimerica hidrosoluble y el uso de dichos compuestos recubiertos en composiciones farmaceuticas

Country Status (24)

Country Link
US (2) US8846101B2 (es)
EP (2) EP2436378B1 (es)
JP (2) JP5368802B2 (es)
KR (2) KR101451954B1 (es)
CN (1) CN101355927B (es)
AR (1) AR058297A1 (es)
AU (1) AU2006322453B2 (es)
BR (1) BRPI0619572B8 (es)
CA (1) CA2631827C (es)
CY (2) CY1115660T1 (es)
DK (2) DK1962807T3 (es)
EA (1) EA018744B1 (es)
ES (2) ES2522544T3 (es)
GE (1) GEP20125596B (es)
IL (2) IL191632A (es)
NO (2) NO340899B1 (es)
NZ (1) NZ568429A (es)
PL (2) PL2436378T3 (es)
PT (2) PT1962807E (es)
SI (2) SI2436378T1 (es)
TW (1) TWI519321B (es)
UA (1) UA95093C2 (es)
WO (1) WO2007065441A1 (es)
ZA (1) ZA200804510B (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE534876T1 (de) * 2004-09-21 2011-12-15 Iglesias Vives Joan Verfahren und maschine zum sintern und/oder trocknen von pulvermaterialien unter verwendung von infrarotstrahlung
GB2447019A (en) * 2007-02-27 2008-09-03 Apatech Ltd Bone-replacement material
DE102008012015A1 (de) * 2008-03-01 2009-09-10 Südzucker AG Mannheim/Ochsenfurt Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
BRPI0921599B8 (pt) * 2008-11-17 2021-05-25 Nycomed Pharma As método para a preparação de um comprimido, e, comprimido de carbonato de cálcio
EP2210595A1 (en) * 2009-01-14 2010-07-28 LEK Pharmaceuticals d.d. Active coating of pharmaceutical dosage forms
AU2010309784B2 (en) * 2009-10-20 2016-11-10 Herbonis Ag Composition comprising Solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
US20110300216A1 (en) * 2010-06-03 2011-12-08 First Eric R Chewable, swallowable and effervescent solid dosage form for oral delivery of pharmaceutical actives
US8821942B1 (en) * 2011-04-06 2014-09-02 Access Business Group International Llc Highly compressible, low density ground calcium carbonate granulation and a related method of preparation
AR089857A1 (es) * 2012-02-02 2014-09-24 Glaxosmithkline Llc Comprimido antiacido para refrescar el aliento
EP2836083B1 (en) 2012-04-10 2016-08-03 Alpinia Laudanum Institute Of Phytopharmaceutical Sciences AG Wet granulation process and granulate material comprising arabic gum
CN102823872B (zh) * 2012-08-22 2014-01-15 安徽泰格生物技术股份有限公司 包膜乳酸钙颗粒及其制备方法
BR112015021630A2 (pt) * 2013-03-07 2017-07-18 Amneal Pharmaceuticals Llc estabilização de fármacos sensíveis à umidade
US8728428B1 (en) 2013-03-13 2014-05-20 Carbon Engineering Limited Partnership Recovering a caustic solution via calcium carbonate crystal aggregates
US9637393B2 (en) * 2014-05-19 2017-05-02 Carbon Engineering Limited Partnership Recovering a caustic solution via calcium carbonate crystal aggregates
US11602542B2 (en) * 2014-07-31 2023-03-14 Amorphical Ltd. Non-aqueous liquid and semi-solid formulations of amorphous calcium carbonate
BR112017005362A2 (pt) * 2014-09-17 2018-01-23 Steerlife India Private Ltd composição, forma de dosagem sólida oral, processo para preparação de grânulos efervescentes porosos, processador de parafuso duplo, e, grânulos efervescentes porosos.
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물
CN106265725B (zh) * 2015-05-14 2021-02-09 北京科信必成医药科技发展有限公司 一种碳酸钙掩味颗粒剂及其制备方法
BR112018000255B1 (pt) * 2015-07-14 2022-03-15 Centre National De La Recherche Scientifique Composição adjuvante, composição pesticida compreendendo a mesma, método para tratamento de um organismo alvo para controlar o crescimento do organismo, solução de tanque agrícola e método para preparar a solução de tanque agrícola
CN106420808B (zh) * 2015-08-11 2019-07-19 北京远方通达医药技术有限公司 一种含有维生素d3和碳酸钙的制剂及其制备方法
KR20180062063A (ko) 2016-11-30 2018-06-08 (주) 메티메디제약 서방형 항암용 약학 조성물
RU2643922C1 (ru) * 2017-06-07 2018-02-06 федеральное государственное бюджетное образовательное учреждение высшего образования Кубанский государственный медицинский университет Министерства Здравоохранения Российской Федерации (ФГБОУ ВО КубГМУ, Минздрава России) Гидрогель для замещения дефектов биологических тканей
KR101856905B1 (ko) * 2017-08-21 2018-06-11 박삼목 염화칼슘 성분이 함유된 리필용 습기제거제 및 이를 이용한 보충용 용기
JP7290870B2 (ja) 2018-01-12 2023-06-14 メティメディ ファーマシューティカルズ カンパニー リミテッド 慢性炎症性疾患を処置する方法
CN108420797B (zh) * 2018-05-09 2022-05-03 南京海融制药有限公司 维生素d类似物制剂及其制备方法
ES2986686T3 (es) * 2018-10-04 2024-11-12 Budenheim Kg Chemische Fabrik Perlas esféricas para su uso en la producción de pellas farmacéuticamente activas
KR102155235B1 (ko) * 2020-01-13 2020-09-11 주식회사 뉴팜 탄산분말을 이용한 기능성 식품
GB202001237D0 (en) * 2020-01-29 2020-03-11 Sisteks D O O Granular pharmaceutical product for oral administration from a pre-filled straw and method of manufacturing such pharmaceutical product
CN111973574B (zh) * 2020-07-28 2022-04-08 健民药业集团股份有限公司 一种维生素d类似物微球及其制备方法
EP4432860A1 (en) * 2021-11-16 2024-09-25 DSM IP Assets B.V. High potency granules obtainable by continuous melt granulation
US20240261290A1 (en) * 2023-02-06 2024-08-08 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising 7-(4-chlorobenzyl)-1-(3-hydroxypropyl)-3-methyl-8-(3-(trifluoromethoxy)-phenoxy)-3,7-dihydro-1h-purine-2,6-dione
IT202300020562A1 (it) * 2023-10-04 2025-04-04 S I I T S R L Servizio Int Imballaggi Termosaldanti Granulato a rilascio modificato di principi attivi e/o ingredienti nutrizionali
CN119725521B (zh) * 2025-02-28 2025-08-26 广东邦普循环科技有限公司 一种磷酸铁锂材料及其制备方法、正极极片和二次电池

Family Cites Families (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE760328A (fr) * 1969-12-15 1971-06-14 Sandoz Sa Nouvelle association medicamenteuse
US4162319A (en) * 1974-08-28 1979-07-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Ring substituted pyrazino-isoquinoline derivatives and their preparation
DE2441261A1 (de) * 1974-08-28 1976-03-18 Merck Patent Gmbh Ringsubstituierte pyrazino-isochinolin-derivat und verfahren zu ihrer herstellung
CA1165242A (en) 1981-07-01 1984-04-10 Hovsep Simonian Compressed and formed alkaline component suitable for use in buffered acetylsalicylic acid product
US4664915A (en) * 1981-07-01 1987-05-12 Bristol-Myers Company Compressed and formed alkaline component suitable for use in buffered aspirin product
US4684534A (en) 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
CA1279574C (en) * 1985-04-17 1991-01-29 Jeffrey L. Finnan Process for lubricating water-soluble vitamin powders
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
DE4006734C1 (es) * 1990-03-03 1991-07-25 Benckiser-Knapsack Gmbh, 6802 Ladenburg, De
US5204115A (en) 1990-12-12 1993-04-20 Suomen Xyrofin Oy Directly compressible xylitol and method
JP2995226B2 (ja) 1992-03-03 1999-12-27 日本ワイスレダリー株式会社 カルシウム含有チユアブル錠
US5965162A (en) * 1993-09-10 1999-10-12 Fuisz Technologies Ltd. Process for forming chewable quickly dispersing multi-vitamin preparation and product therefrom
US5405623A (en) 1993-09-22 1995-04-11 Wm. Wrigley Jr. Company Chewing gum compositions and methods for manufacturing same
DE4427137B4 (de) 1993-10-07 2007-08-23 Degussa Gmbh Fällungskieselsäure
FR2717387B1 (fr) * 1994-03-17 1996-10-18 Hi Pharmtech Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
US6716454B2 (en) * 1994-09-23 2004-04-06 Laboratorie Innothera, Société Anonyme Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
FR2724844B1 (fr) 1994-09-23 1997-01-24 Innothera Lab Sa Association therapeutique vitamino-calcique, son procede d'obtention et son utilisation
US5846506A (en) * 1994-10-07 1998-12-08 Degussa Aktiengesellschaft Precipitated silicas
DE19617487A1 (de) 1996-05-02 1997-11-06 Merck Patent Gmbh Geschmacksverbesserung von Arzneimittelwirkstoffen
CA2258159C (en) 1996-06-14 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Intraorally rapidly disintegrable tablet
JPH10108647A (ja) 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
FR2762217B1 (fr) 1997-04-16 2000-09-29 Besins Iscovesco Lab Preparation solide vitamino-calcique, son procede d'obtention et son utilisation
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
ITFI970184A1 (it) 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
KR20010030798A (ko) 1997-09-30 2001-04-16 스즈키 다다시 경구 투여 제제
IL136831A0 (en) * 1997-12-19 2001-06-14 Smithkline Beecham Corp Process for manufacturing bite-dispersion tablets
PE20000559A1 (es) * 1998-05-27 2000-07-05 Merck & Co Inc Formulacion de tabletas comprimidas de efavirenz
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
DK1150918T3 (da) * 1999-02-03 2004-12-20 Biosante Pharmaceuticals Inc Fremgangsmåde til fremstilling af terapeutiske calciumphosphatpartikler
DE19927537A1 (de) 1999-06-16 2000-12-21 Merck Patent Gmbh Sprühtrocknungsanlage und Verfahren zu ihrer Verwendung
EP1116485A3 (de) 2000-01-10 2002-01-16 Gerhard Dr. Gergely Instant-Granulat und Verfahren zu seiner Herstellung
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
DK1126017T3 (da) 2000-02-18 2006-02-06 Glatt Ingtech Gmbh Fremgangsmåde til fremstilling af höjeffektive vaskemidler og komponenter i höjeffektive vaskemidler
SK284948B6 (sk) 2000-04-06 2006-03-02 Zentiva, A. S. Liečivý prípravok s obsahom vápnika alebo zmesi vápnika a vitamínu D, alebo zmesi vápnika a horčíka v novej liekovej forme
AR028064A1 (es) 2000-05-03 2003-04-23 Omnia Fertilizer Ltd Metodo para producir granulos de nitrato de calcio
JP2001316249A (ja) 2000-05-11 2001-11-13 Lion Corp 錠剤型医薬組成物
US6419954B1 (en) * 2000-05-19 2002-07-16 Yamanouchi Pharmaceutical Co., Ltd. Tablets and methods for modified release of hydrophilic and other active agents
JP2002087965A (ja) 2000-09-14 2002-03-27 Lion Corp 口中崩壊性アスピリン含有錠剤
IT1319685B1 (it) 2000-12-12 2003-10-23 Ursula Mariah Rothlin Formulazioni alimentari ad elevato contenuto di calcio.
US7303763B2 (en) 2001-02-12 2007-12-04 Watson Laboratories, Inc. Compositions for conjugated estrogens and associated methods
CA2440361A1 (en) * 2001-03-06 2002-09-12 Kyowa Hakko Kogyo Co. Ltd. Intraorally rapidly disintegrable preparation
AU2002238848B2 (en) 2001-03-06 2007-11-15 Kyowa Hakko Kogyo Co., Ltd. Use of a spray-dried powder comprising a sugar alcohol
JP3825269B2 (ja) 2001-03-13 2006-09-27 三菱重工業株式会社 ターボクーリングシステム
WO2003053399A2 (en) * 2001-12-21 2003-07-03 Pfizer Products Inc. Methods for wet granulating azithromycin
WO2004047810A1 (en) 2002-11-25 2004-06-10 Purdue Research Foundation Mannose-based fast dissolving tablets
JP4578124B2 (ja) * 2003-03-12 2010-11-10 武田薬品工業株式会社 高濃度に活性成分を球形核に付着させた医薬組成物
CA2518780C (en) * 2003-03-12 2014-05-13 Takeda Pharmaceutical Company Limited Drug composition having active ingredient adhered at high concentration to spherical core
US20070178150A1 (en) 2003-07-10 2007-08-02 Prasad Adusumilli Pharmaceutical compositions
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
US20050244493A1 (en) 2004-04-30 2005-11-03 Withiam Michael C Rapidly disintegrating tablets comprising calcium carbonate
UA85717C2 (uk) * 2004-05-24 2009-02-25 Нікомед Фарма Ас Сипкий матеріал, який містить кальцієвмісну сполуку і цукровий спирт
BE1016566A4 (fr) 2004-05-25 2007-02-06 Psaltopoulos Emmanuel Procede pour fournir les besoins quotidiens de l'etre humain en calcium (ca), en vitamine "d" et en vitamine "k" sous forme de pilule a croquer ou a avaler.
US20060068005A1 (en) 2004-09-30 2006-03-30 Pal Laboratories, Inc. Chewable electrolyte tablet
MX2007004741A (es) 2004-10-21 2007-09-07 Eurand Pharmaceuticals Ltd Composiciones farmaceuticas con sabor enmascarado con formadores de poro gastrosolubles.
ES2255429B1 (es) 2004-10-25 2007-08-16 Italfarmaco, S.A. Composiciones farmaceuticas bucodispersables.
US20090142401A1 (en) 2005-06-07 2009-06-04 Leah Elizabeth Appel Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release
BE1016895A6 (fr) 2005-12-16 2007-09-04 Psaltopoulos Emmanuel MOLECULE INCORPORANT LE CALCIUM (CA), LA VITAMINE "D" ET LA VITAMINE "K" POUR LA PREVENTION ET LE TRAITEMENT DE l'OSTEOPOROSE AINSI QUE POUR LA PREVENTION DE LA CALCIFICATION VASCULAIRE ET POUR LA PREVENTION DE LA CALCIFICATION DU CARTILAGE DES ARTICULATIONS.
AR061093A1 (es) 2006-05-12 2008-08-06 Drug Tech Corp Composiciones de calcio
FI20080352A0 (fi) 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi korkean lääkepitoisuuden tabletin valmistamiseksi
FI20080351A0 (fi) 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi matalan lääkepitoisuuden tabletin valmistamiseksi
FI20080346A0 (fi) 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
WO2008087595A2 (en) 2007-01-16 2008-07-24 Koninklijke Philips Electronics N.V. Device discovery for mixed types of directional terminals
CA2835910C (en) 2007-04-25 2016-06-28 Warner Chilcott Company, Llc Improved vitamin d content uniformity in pharmaceutical dosage forms
WO2008141333A1 (en) 2007-05-14 2008-11-20 Cadbury Adams Usa Llc Taste potentiator compositions in oral delivery systems
CA2688389A1 (en) 2007-06-06 2008-12-11 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
JP2010529073A (ja) 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア チュアブル錠及びトローチ剤製造のための医薬製剤
ES2639130T3 (es) 2007-06-06 2017-10-25 Basf Se Formulación farmacéutica para la fabricación de comprimidos de rápida desintegración
ES2646112T3 (es) 2007-06-06 2017-12-12 Basf Se Formulación farmacéutica para la fabricación de comprimidos que se desintegran rápidamente
WO2009100271A1 (en) 2008-02-07 2009-08-13 Ralph Brown Prevention of micronutrient deficiencies associated with common disabilities in the over 50 adult
FR2928269B1 (fr) 2008-03-05 2011-10-07 Innothera Chouzy Formulation pharmaceutique orale sous forme unitaire de comprime soluble ou dispersible, notamment effervescent, appropriee a une fabrication par compression
US8324191B2 (en) 2008-07-11 2012-12-04 Biolink Life Sciences, Inc Combined calcium, magnesium and vitamin D supplements
US20100068347A1 (en) 2008-09-15 2010-03-18 Yael Policker Nutraceutical sweetener composition

Also Published As

Publication number Publication date
AU2006322453A1 (en) 2007-06-14
CA2631827C (en) 2016-09-13
KR101451954B1 (ko) 2014-10-16
US20090252805A1 (en) 2009-10-08
NZ568429A (en) 2012-04-27
US9801907B2 (en) 2017-10-31
CN101355927A (zh) 2009-01-28
PL1962807T3 (pl) 2015-03-31
DK2436378T3 (da) 2014-11-03
BRPI0619572B1 (pt) 2020-11-17
IL191632A0 (en) 2008-12-29
EP2436378A1 (en) 2012-04-04
AU2006322453B2 (en) 2013-03-07
CY1115660T1 (el) 2017-01-25
ZA200804510B (en) 2015-04-29
ES2521640T3 (es) 2014-11-13
ES2522544T3 (es) 2014-11-17
EP1962807B1 (en) 2014-08-06
KR20140037278A (ko) 2014-03-26
NO20082903L (no) 2008-07-01
TW200730184A (en) 2007-08-16
IL244761B (en) 2018-07-31
JP5368802B2 (ja) 2013-12-18
KR101554355B1 (ko) 2015-09-18
GEP20125596B (en) 2012-08-10
UA95093C2 (uk) 2011-07-11
EA200870007A1 (ru) 2009-02-27
KR20080081020A (ko) 2008-09-05
PT1962807E (pt) 2014-10-29
US8846101B2 (en) 2014-09-30
SI1962807T1 (sl) 2014-12-31
EP2436378B1 (en) 2014-08-06
PT2436378E (pt) 2014-10-29
US20150050353A1 (en) 2015-02-19
JP2013209403A (ja) 2013-10-10
TWI519321B (zh) 2016-02-01
HK1126122A1 (en) 2009-08-28
BRPI0619572A8 (pt) 2017-12-19
BRPI0619572A2 (pt) 2012-12-11
NO340899B1 (no) 2017-07-10
SI2436378T1 (sl) 2014-12-31
EA018744B1 (ru) 2013-10-30
WO2007065441A1 (en) 2007-06-14
PL2436378T3 (pl) 2015-04-30
NO20170606A1 (no) 2017-04-10
BRPI0619572B8 (pt) 2021-05-25
IL244761A0 (en) 2016-05-01
CY1115661T1 (el) 2017-01-25
CN101355927B (zh) 2013-04-17
EP1962807A1 (en) 2008-09-03
CA2631827A1 (en) 2007-06-14
NO341860B1 (no) 2018-02-12
JP2009518322A (ja) 2009-05-07
IL191632A (en) 2016-04-21
DK1962807T3 (da) 2014-11-03

Similar Documents

Publication Publication Date Title
AR058297A1 (es) Compuestos que contienen calciorecubiertos con una pelicula polimerica hidrosoluble y el uso de dichos compuestos recubiertos en composiciones farmaceuticas
PE20030803A1 (es) Composiciones farmaceuticas de dispersiones amorfas de farmacos y materiales que forman microfases lipofilas
WO2008149440A1 (ja) 速溶性及び可撓性を有するフィルム製剤
CR11167A (es) Uso de homo y copolimeros para la estabilizacion de formulaciones de principios activos
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
EA200700201A1 (ru) Композиция таблетки пролонгированного высвобождения, содержащая прамипексол или его фармацевтически приемлемую соль, способ ее изготовления и ее применение
EA200801926A1 (ru) Таблетки парацетамола с быстрым высвобождением
BR0312887A (pt) Forma de dosagem farmacêutica de múltiplos componentes
NO20024919D0 (no) Hydrofil/lipofil polymer matriksdoseringsformulering
ATE478840T1 (de) 3-aminoazetidinderivate enthaltende pharmazeutische zusammensetzungen, diese derivate und deren herstellung
SV2008002612A (es) Forma de dosificacion de liberacion retardada oral altamente biodisponibles de succionado de o-desmetilvanlafaxina ref. am101721salvo
AR056754A1 (es) Composiciones para el tratamiento del cabello
PE20001326A1 (es) Composicion farmaceutica que comprende cefuroxima-axetil, polimero y/o adsorbente
CL2004001843A1 (es) Combinacion de (a) al menos un derivado 2,5-dihidrobencenosulfonico, como el dobeilato calcico, etamsilato y persilato, y (b) al menos un modulador de los canales de potasio, composicion farmaceutica que la contiene y uso como medicamento en profilax
ES2517419T3 (es) Artículos adhesivos para dentadura postiza
DE60309472D1 (de) Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant
BRPI0417106A (pt) granulos de pesticida com surfactante melhorado de soltura rápida
DE602004022515D1 (de) Fenofibrate tablett und verfahren zur herstellung
ATE357220T1 (de) Pharmazeutische zusammensetzung mit modifizierter freisetzung
TH94290B (th) สารประกอบชนิดมีแคลเซียมซึ่งได้รับการทำให้เป็นแกรนูลและ/หรือซึ่งได้รับการเคลือบผิวด้วยฟิล์ม และการใช้สารประกอบเหล่านี้ในสารผสมทางเภสัชกรรม
PT1499278E (pt) Forma de dosagem farmaceutica de libertacao imediata compreendendo tibolona polimorfa
ATE479428T1 (de) Olanzapin enthaltende pharmazeutische zusammensetzung
DK1484033T3 (da) Flydende polymersammensætninger til kontrolleret frigivelse af bioaktive stoffer
AR050627A1 (es) Composicion farmaceutica
TH94290A (th) สารประกอบชนิดมีแคลเซียมซึ่งถูกทำให้เป็นแกรนูล และ/หรือ ซึ่งได้รับการเคลือบผิวด้วยฟิล์มและการใช้ของมันในองค์ประกอบทางเภสัชกรรม

Legal Events

Date Code Title Description
FC Refusal